Rebekah Jordan fired out some quick Q&As with the Verseon team to shed light on their PKI treatment for diabetic vision loss, its advantages over injection treatments as well as its effectiveness long term.
Ribbon Biolabs, the DNA synthesis company, announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 11352619 B2, covering Ribbon Biolabs’ novel method for synthesising DNA, using a diverse library of oligonucleotides.
Withers & Rogers gives an insight into the new ways that AI is helping to accelerate drug discovery and highlights the challenges that exist when bringing such innovations to market.
Dave Walsha, sales manager at precision drive system supplier, Electrical Mechanical Systems (EMS), explores how micromotors are helping drug discovery.
Justin Wilson, partner and attorney at Withers & Rodgers, discusses his opinion on the promising innovations in the microbiome and the role of IP in supporting the discovery of new drugs and treatments.
European Pharmaceutical Manufacturer explores the rise of ketamine as treatment for depression and why a recent study shines hope on the drug being used to treat alcohol use disorder.
Dr Katy Taylor, director of Science and Regulatory Affairs at Cruelty Free International discusses the use of dogs within toxicology assessments and why change is needed.
Robert Hewitt founder of Biosample Hub looks at the problems biotechs have in accessing samples within NHS biobanks and what can be done to improve collaboration between the NHS and industry.
Professor Saad Shakir, director of the Drug Safety Research Unit looks at observational research in the UK and why it's one of the nation's core strengths.
Ivor Campbell managing director of Stirlingshire-based Snedden Campbell explores the use of blood tests to diagnose cancer and questions whether the NHS’ latest approach is the right one.
